![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
FDA grants Priority Review to Bristol-Myers Squibb and AstraZeneca’s Metreleptin
Bristol-Myers Squibb Company and AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has...
Musculoskeletal conditions, injuries may be associated with statin use
Using cholesterol-lowering statins may be associated with musculoskeletal conditions, arthropathies (joint diseases) and injuries, according...
Nanotechnology could help fight diabetes
Injectable nanoparticles developed at Massachusetts Institute of Technology (MIT) may someday eliminate the need...
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs...
GSK and Save the Children form unique partnership to save the lives of one...
An ambitious new partnership to save the lives of a million of the poorest...
Breakthrough in how pancreatic cancer cells ingest nutrients points to new drug target
In a landmark cancer study published online in Nature, researchers at NYU School of...
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab)...
Boehringer Ingelheim joins Structural Genomics Consortium
Boehringer Ingelheim has joined the Structural Genomics Consortium (SGC). The consortium intends to promote...
Bristol-Myers Squibb and Pfizer announce publication of ARISTOTLE subanalysis in Circulation
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that results from...
Study opens new prospects for developing new targeted therapies for breast cancer
A study led by prominent breast cancer experts from Europe and the US has...